Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/LCLA stock hub

FRA/LCLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/LCLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/LCLA

In the news

Latest news · FRA/LCLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.8

P25 n/aP50 n/aP75 n/a

Trailing P/E11

P25 n/aP50 n/aP75 n/a

ROE14.4

P25 n/aP50 n/aP75 n/a

ROIC16.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/LCLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

IDR

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	DE
Employees	12,835
Employees Change	-68%
Employees Change Percent	-0.53
Enterprise value	EUR 1.9B
Exchange	Frankfurt Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 2B
Price	EUR 0.04
Price currency	EUR
Rev Per Employee	143,690.55x
Sic	2834
Symbol	fra/LCLA
Website	https://www.kalbe.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.08%
EV Earnings	10.27x
EV/EBIT	8.46x
EV/EBITDA	7.21x
EV/FCF	15.15x
EV/Sales	1.07x
FCF yield	6.16%
Forward P/E	10.81x
P/B ratio	1.55x
P/E ratio	11.01x
P/S ratio	1.1x
PE Ratio10 Y	25.87x
PE Ratio3 Y	21.1x
PE Ratio5 Y	22.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.47%
EBITDA Margin	14.61%
FCF margin	6.77%
Gross margin	38.32%
Gross Profit	EUR 710.1M
Gross Profit Growth	6.22%
Gross Profit Growth Q	2.21%
Gross Profit Growth3 Y	5.65%
Gross Profit Growth5 Y	6.56%
Net Income	EUR 185.1M
Net Income Growth	7.66%
Net Income Growth Q	-4.44%
Net Income Growth3 Y	2.05%
Net Income Growth5 Y	5.4%
Pretax Margin	13.06%
Profit Margin	9.99%
Profit Per Employee	EUR 14,352
ROA	9.02
Roa5y	9.5
ROCE	17.11
ROE	14.43
Roe5y	14.67
ROIC	16.71
Roic5y	17.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.57%
Div CAGR10	-62.58%
Div CAGR3	-96.03%
Div CAGR5	-84.93%
EPS Growth	9.15
EPS Growth Q	-3.52
EPS Growth3 Y	2.82
EPS Growth5 Y	6.07
FCF Growth	-20.5%
FCF Growth Q	-45.95%
FCF Growth3 Y	83.9%
FCF Growth5 Y	-5.6%
OCF Growth	-18.68%
OCF Growth Q	-23.32%
OCF Growth10 Y	3.92%
OCF Growth3 Y	41.12%
OCF Growth5 Y	-4.26%
Revenue Growth	9.57x
Revenue Growth Q	9.42x
Revenue Growth3 Y	6.73x
Revenue Growth5 Y	9.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.16
Assets	EUR 1.6B
Cash	EUR 232.6M
Current Assets	EUR 971.8M
Current Liabilities	EUR 273.3M
Debt	EUR 15.6M
Debt EBITDA	EUR 0.06
Debt Equity	EUR 0.01
Debt FCF	EUR 0.12
Equity	EUR 1.3B
Interest Coverage	148.3
Liabilities	EUR 319.8M
Long Term Assets	EUR 664.7M
Long Term Liabilities	EUR 46.5M
Net Cash	EUR 217M
Net Cash By Market Cap	EUR 10.64
Net Cash Growth	2.08%
Net Debt EBITDA	EUR -0.8
Net Debt Equity	EUR -0.16
Net Debt FCF	EUR -1.73
Tangible Book Value	EUR 1.1B
Tangible Book Value Per Share	EUR 0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.56
Inventory Turnover	3.16
Net Working Capital	EUR 506.6M
Quick ratio	1.99
Working Capital	EUR 732.4M
Working Capital Turnover	EUR 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.37%
Dividend Growth	-99.99%
Dividend Growth Years	0%
Dividend per share	EUR 0
Dividend Years	2
Dividend Yield	5.25%
Ex Div Date	2025-06-04
Last Dividend	EUR 0
Payout Ratio	45.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-44.55%
200-day SMA	0.05
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
All Time High	0.09
All Time High Change	-60.64%
All Time High Date	2024-09-27
All Time Low	0.01
All Time Low Change	640%
All Time Low Date	2024-11-11
ATR	0
Ch YTD	21.31
High	0.04
High52	0.09
High52 Date	2025-06-06
High52ch	-58.89%
Low	0.04
Low52	0.03
Low52 Date	2026-01-02
Low52ch	21.31%
Ma50ch	-14.15%
Price vs 200-day SMA	-31.61%
RSI	45.23
RSI Monthly	33.81
RSI Weekly	38.17
Sharpe ratio	0.3x
Sortino ratio	0.59
Total Return	6.61%
Tr YTD	21.31
Tr1m	-14.94%
Tr1w	8.82%
Tr3m	-27.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 231M
Operating Income Growth	6.17
Operating Income Growth Q	-5.65
Operating Income Growth3 Y	1.61
Operating Income Growth5 Y	4.37
Operating margin	12.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,993,154,741%
Net Borrowing	-12,654,222.3
Shares Insiders	0.35%
Shares Institutions	8.64%
Shares Qo Q	-0.57%
Shares Yo Y	-1.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 125.5M
Average Volume	312.25x
Bv Per Share	0.03
CAPEX	EUR -37.8M
Ch1m	-14.94
Ch1w	8.82
Ch1y	-45.99
Ch3m	-27.45
Ch6m	-38.33
Change	2.78%
Change From Open	5.71
Close	0.04
Days Gap	-2.78
Depreciation Amortization	37,890,583.4
Earnings Date	2026-05-13
EBIT	EUR 231M
EBITDA	EUR 270.7M
EPS	EUR 0
F Score	5
FCF	EUR 125.5M
FCF EV Yield	6.6x
Financing CF	-128,232,845
Fiscal Year End	December
Founded	1,966
Graham Number	0.0425
Graham Upside	14.86
Income Tax	EUR 53.4M
Investing CF	-42,352,536
Is Primary Listing	0
Last Report Date	2026-03-31
Last Split Date	2012-10-08
Last Split Type	Forward
Lynch Fair Value	EUR 0.02
Lynch Upside	-50.95
Ma150	0.05
Ma150ch	-26.73%
Ma20	0.04
Ma20ch	-2.63%
Net CF	-7,681,456
Next Earnings Date	2026-05-13
Open	0.04
P FCF Ratio	16.25
P OCF Ratio	12.49
Payment Date	2025-06-25
Position In Range	100
Ppne	409,255,106.7
Price Date	2026-05-08
Price EBITDA	EUR 7.53
Ptbv Ratio	1.81
Relative Volume	2,000x
Revenue	1,852,889,678x
Tax By Revenue	2.88x
Tax Rate	22.06%
Tr6m	-38.33%
Z Score	8.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/LCLA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.2%

$0.00 annual per share

Payout ratio

+45.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-84.9%

0 consecutive years of growth

Total shareholder yield

+6.6%

Next ex-dividend date: 2025-06-04

Performance

FRA/LCLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/LCLA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.6%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.4%

Negative means the company is buying back shares.

Technical

FRA/LCLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.2

Neutral momentum band

Price vs 200-day MA

-31.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/LCLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/LCLA stock rating?

fra/LCLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/LCLA analysis?

The full report lives at /stocks/fra/LCLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/LCLA?

The latest report frames fra/LCLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/LCLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.